- From: Jeremy Teoh <jeremyyjteoh@googlemail.com>
- Date: Wed, 19 Oct 2022 00:13:15 +0100
- To: public-hclscg@w3.org, david@dbooth.org
- Message-ID: <CA+B8FqrcKKVH9z7H-bQgOJkpP6PWpXt443h3axHpDic3dX9nrA@mail.gmail.com>
Is anyone else out there using JSON-LD with clinical trials? I have been working on the CDISC Open Source Alliance Dataset-JSON hackathon, experimenting with JSON-LD to make sense of CDISC data. The hackathon is demonstrating the overwhelming advantages of using JSON over SAS' ancient .xpt format that is still mandated by regulatory authorities. One outcome is draft JSON-LD context content to accompany the proposed JSON-format CDISC content. (my clumsy efforts <https://github.com/TeMeta/Dataset-JSON_hackathon> are an exploration that started as a way to learn a new language/stack, and ended up as an obsession with JSON-LD). The time is right for clinical trial dataset metadata to have the opportunity to join the semantic web. - the introduction of Biomedical Concepts over the coming years will necessitate a more graph-based approach - JSON seems the obvious successor to XPT for clinical trial submissions, there has been significant interest in this hackathon - JSON-LD is an ingenious bridge between machine-readable graphs and human-readable datasets - CDISC needs a more interoperable format like FHIR Let me know if anyone else is interested in developing JSON-LD for CDISC I can be reached at jeremyyjteoh@gmail.com Thanks!
Received on Thursday, 20 October 2022 08:21:16 UTC